| Ashley Lynn Kamer, CNP | |
|
4157 State Route 1, Argillite, KY 41121-8358 | |
| (606) 408-8921 | |
| (606) 408-8908 |
| Full Name | Ashley Lynn Kamer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 4157 State Route 1, Argillite, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992339642 | NPI | - | NPPES |
| Entity Name | Ashland Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659328250 PECOS PAC ID: 7719882521 Enrollment ID: O20031204000877 |
News Archive
SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute, part of the National Institutes of Health, to create reference materials and positive controls for cancer assays.
A recent study demonstrates that antibodies generated in response to mRNA-based COVID-19 vaccination target more epitopes across the spike protein.
A new study reveals that many patients with breast cancer have misconceptions and fears about radiation therapy, but their actual experiences with modern breast radiation therapy are better than they expected.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Lynn Kamer, CNP 2201 Lexington Ave, Ashland, KY 41101-2843 Ph: (606) 408-4000 | Ashley Lynn Kamer, CNP 4157 State Route 1, Argillite, KY 41121-8358 Ph: (606) 408-8921 |
News Archive
SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, today announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute, part of the National Institutes of Health, to create reference materials and positive controls for cancer assays.
A recent study demonstrates that antibodies generated in response to mRNA-based COVID-19 vaccination target more epitopes across the spike protein.
A new study reveals that many patients with breast cancer have misconceptions and fears about radiation therapy, but their actual experiences with modern breast radiation therapy are better than they expected.
BioLight Life Sciences Investments, a company focused primarily on the discovery, development and commercialization of breakthrough ophthalmic diagnostics and therapeutics, announced today that it has entered into a joint financing agreement (the "Agreement") with two Asia-based venture capital firms (the "New Investors"), pursuant to which BioLight and the New Investors will make a direct equity investment in BioLight's IOPtima Ltd. subsidiary via a private placement.
› Verified 6 days ago
Barbara Jane Bloom, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 474 Litteral Ln, Argillite, KY 41121 Phone: 606-585-7211 |